Brief: Elicera Therapeutics Resolves On Directed Issue Of Over 1.5 Mln Shares
20/03/2025 11:34
March 20 (Reuters) - Elicera Therapeutics AB ELIC.ST: RESOLVES ON DIRECTED ISSUE OF 1,533,512 SHARES SUBSCRIPTION PRICE IN COMPENSATION ISSUE SET AT SEK 1.85 Source text: ID:nWkr52lDVg Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent